4.4 Article

Cotransfection of Poly(I:C) and siRNA of IL-10 Into Fusions of Dendritic and Glioma Cells Enhances Antitumor T Helper Type 1 Induction in Patients With Glioma

Journal

JOURNAL OF IMMUNOTHERAPY
Volume 34, Issue 2, Pages 121-128

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/CJI.0b013e3181e5c278

Keywords

dendritic cell; glioma; Th1; polyriboinosinic polyribocytidylic acid; small interference RNA

Funding

  1. Ministry of Education, Science, and Technology of Japan [C-19591704]
  2. Grants-in-Aid for Scientific Research [19591704] Funding Source: KAKEN

Ask authors/readers for more resources

Apart from generating T-helper (Th) effector responses, dendritic cells (DCs) are capable of initiating tolerance against the inciting antigens. Therefore, successful DC-based immunotherapy against malignant tumors requires an additional strategy to activate antigen-processing DCs. We studied the antitumor immune responses conferred by fusions of DCs and glioma cells in vitro. Fusion cells (FCs) were stimulated with polyriboinosinic polyribocytidylic acid [Poly(I:C)] and/or small interference RNA (siRNA) of IL-10 (IL-10-siRNA). Increased IFN-beta expression induced by Poly(I: C) transfection was accompanied by enhanced production of IL-10 and IL-12p70 in the FCs. We also found that the ability of Poly(I:C)-transfected FCs to produce IL-12p70, but not IFN-beta, was preserved when endogenous IL-10 was suppressed by IL-10-siRNA. To analyze the antigen-presenting function further, DCs, glioma cells, and peripheral lymphocytes were established from patients newly diagnosed with glioma. In this experiment, peripheral lymphocytes were stimulated with autologous FCs and restimulated with autologous glioma cells. CD4(+) T cells isolated from the stimulated lymphocytes were subjected to the ELISPOT and WST-1 assays, which revealed that the IL10-siRNA/Poly(I:C)-cotransfected FCs elicit an efficient tumor-specific Th1 response. These findings support the relevance of using Poly(I:C) and IL-10-siRNA in clinical immunotherapy protocols with an FC-based vaccine for patients with malignant glioma as a means of promoting Th1-induced tumor antigen presentation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

Significantly high concentrations of vascular endothelial growth factor in chronic subdural hematoma with trabecular formation

Jun Takei, Toshihide Tanaka, Yohei Yamamoto, Keisuke Hatano, Diasuke Ichinose, Fumiaki Maruyama, Satoru Tochigi, Yuzuru Hasegawa, Yuichi Murayama

Summary: The study found that the group with high hematoma density had the highest VEGF concentration, while the recurrence rate of CSDH was highest in the separated group with low hematoma density. There was a significant correlation between VEGF concentration and CT classification, indicating a predictive value of VEGF concentration in the natural history of chronic subdural hematoma.

CLINICAL NEUROLOGY AND NEUROSURGERY (2021)

Article Clinical Neurology

Avoidance and Improvement in Visual Field Defect After Surgery for Metastatic Brain Tumors in the Parietal and the Occipital Lobe

Toshihide Tanaka, Jun Takei, Akihiko Teshigawara, Yohei Yamamoto, Yasuharu Akasaki, Yuzuru Hasegawa, Yuichi Murayama

Summary: The study indicated that surgery for brain metastatic tumors near the optic radiation could improve hemianopsia in some patients. Factors such as tumor location, resection rate, and postoperative Karnofsky performance scale score had an impact on visual field improvement.

WORLD NEUROSURGERY (2021)

Review Medicine, General & Internal

Delayed Tentorial Subdural Hematoma Caused by Traumatic Posterior Cerebral Artery Aneurysm: A Case Report and Literature Review

Michiyasu Fuga, Toshihide Tanaka, Ryo Nogami, Rintaro Tachi, Akihiko Teshigawara, Toshihiro Ishibashi, Yuzuru Hasegawa, Yuichi Murayama

Summary: This study presents a case of delayed subdural hematoma caused by posterior cerebral artery aneurysm, which was successfully treated with parent artery occlusion resulting in a good outcome for the patient.

AMERICAN JOURNAL OF CASE REPORTS (2021)

Article Clinical Neurology

Risk factors for recanalization of dense coil packing for unruptured cerebral aneurysms in endovascular coil embolization: Analysis of a single center's experience

Michiyasu Fuga, Toshihide Tanaka, Koreaki Irie, Ikki Kajiwara, Rintaro Tachi, Akihiko Teshigawara, Toshihiro Ishibashi, Yuzuru Hasegawa, Yuichi Murayama

Summary: This retrospective study analyzed 301 unruptured aneurysms and found that RROC class 3 and aneurysm volume were independent predictors of recanalization. Cases with RROC class 3 or high aneurysm volume may have a higher risk of recanalization and should be closely monitored during coil embolization.

JOURNAL OF CLINICAL NEUROSCIENCE (2022)

Editorial Material Immunology

Editorial: The Impact of Angiogenic Growth Factors and Hypoxia on the Antitumor Immune Response

Loredana Albonici, Sara Labiano Alminana, Toshihide Tanaka, Roberto Bei

FRONTIERS IN IMMUNOLOGY (2022)

Article Oncology

Impact of Neoadjuvant Bevacizumab on Neuroradiographic Response and Histological Findings Related to Tumor Stemness and the Hypoxic Tumor Microenvironment in Glioblastoma: Paired Comparison Between Newly Diagnosed and Recurrent Glioblastomas

Jun Takei, Nei Fukasawa, Toshihide Tanaka, Yohei Yamamoto, Ryota Tamura, Hikaru Sasaki, Yasuharu Akasaki, Yuko Kamata, Mutsunori Murahashi, Masayuki Shimoda, Yuichi Murayama

Summary: A pseudo-papillary structure was observed in recurrent GBM after anti-vascular endothelial growth factor therapy. Bev may enhance tumor oxygenation, inhibit stemness, and correlate with neuroimaging response during treatment. FOXM1 could serve as a survival biomarker in the context of Bev therapy.

FRONTIERS IN ONCOLOGY (2022)

Article Neurosciences

Thromboelastography 6s for assessment of platelet function during coil embolization of unruptured intracranial aneurysms

Michiyasu Fuga, Toshihide Tanaka, Rintaro Tachi, Kyoichi Tomoto, Ryoto Wachi, Akihiko Teshigawara, Toshihiro Ishibashi, Yuzuru Hasegawa, Yuichi Murayama

Summary: This study aimed to assess the associations between thromboelastography 6s (TEG6s) measurements and postoperative ischemic complications in patients with unruptured intracranial aneurysms (UIAs) treated by coil embolization. The results showed that MAADP and ADP% can serve as reliable parameters to predict postoperative ischemic complications after coil embolization of UIAs.

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2023)

Article Clinical Neurology

A novel 3-Fr guiding sheath for transradial access in aneurysm embolization: Technical note

Michiyasu Fuga, Toshihide Tanaka, Rintaro Tachi, Ryoto Wachi, Akihiko Teshigawara, Toshihiro Ishibashi, Yuzuru Hasegawa, Yuichi Murayama

Summary: This study describes the use of a novel 3-Fr guiding sheath for aneurysm embolization via transradial access in patients with narrow radial arteries. The procedure was successful and complications were avoided.

INTERVENTIONAL NEURORADIOLOGY (2022)

Article Neuroimaging

Therapeutic efficacy and complications of radial versus femoral access in endovascular treatment of unruptured intracranial aneurysms

Michiyasu Fuga, Toshihide Tanaka, Rintaro Tachi, Kyoichi Tomoto, Shun Okawa, Akihiko Teshigawara, Toshihiro Ishibashi, Yuzuru Hasegawa, Yuichi Murayama

Summary: The study aimed to compare the efficacy and complications of transradial approach (TRA) and transfemoral approach (TFA) in coil embolization of unruptured intracranial aneurysms (UIAs). Results showed that coil embolization via TRA can reduce the risk of minor access site complications (ASCs) without increasing the risk of non-ASCs compared with conventional TFA, and achieve comparable results in terms of efficacy and fluoroscopy time.

NEURORADIOLOGY JOURNAL (2023)

Article Clinical Neurology

Contrast Injection from an Intermediate Catheter Placed in an Intradural Artery is Associated with Contrast-Induced Encephalopathy following Neurointervention

M. Fuga, T. Tanaka, R. Tachi, S. Yamana, K. Irie, I. Kajiwara, A. Teshigawara, T. Ishibashi, Y. Hasegawa, Y. Murayama

Summary: A retrospective study on 396 patients who underwent neurointervention for cerebral aneurysms found that contrast injection from an intradural artery and retreatment of recurrent aneurysms were major risk factors for contrast-induced encephalopathy.

AMERICAN JOURNAL OF NEURORADIOLOGY (2023)

Article Oncology

Prognostic survival biomarkers of tumor-fused dendritic cell vaccine therapy in patients with newly diagnosed glioblastoma

Jun Takei, Yuko Kamata, Toshihide Tanaka, Nei Fukasawa, Kazutaka Gomisawa, Mari Satake, Ryosuke Mori, Yohei Yamamoto, Tomoya Suzuki, Ayaka Oda, Mutsunori Murahashi, Takahiro Fukuda, Masayuki Shimoda, Yuichi Murayama, Yasuharu Akasaki

Summary: This study investigated the prognostic factors in patients receiving tumor-fused dendritic cell (TFDC) immunotherapy for glioblastoma (GBM). It found that TFDC immunotherapy showed clinical activity against GBM, especially in patients with O-6-methylguanine-DNA methyltransferase (MGMT) unmethylated tumors, with a 5-year survival rate of 33%.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2023)

Article Clinical Neurology

Efficacy and safety of fetal posterior cerebral artery stented coil embolization for fetal posterior cerebral aneurysms

Michiyasu Fuga, Toshihide Tanaka, Rintaro Tachi, Koreaki Irie, Ikki Kajiwara, Akihiko Teshigawara, Toshihiro Ishibashi, Yuzuru Hasegawa, Yuichi Murayama

Summary: Stenting into the fetal posterior cerebral artery (fPCA) can provide effective embolization and prevent recanalization for aneurysms with fPCA incorporated into the aneurysm. This study found that the stenting group achieved significantly higher complete occlusion rate and packing density compared to the non-stenting group, with no major complications observed. Therefore, fPCA stent-assisted coil embolization can be considered as an alternative treatment for fPCA aneurysms.

INTERVENTIONAL NEURORADIOLOGY (2023)

Article Clinical Neurology

Risk factors for radial artery occlusion after neurointervention for unruptured intracranial aneurysm via transradial access

Michiyasu Fuga, Toshihide Tanaka, Rintaro Tachi, Kyoichi Tomoto, Kenta Kazami, Akihiko Teshigawara, Toshihiro Ishibashi, Yuzuru Hasegawa, Yuichi Murayama

Summary: This study aimed to explore the risk factors for radial artery occlusion (RAO) after coil embolization of unruptured intracranial aneurysms (UIAs) via transradial access (TRA). The results showed that radial artery size and radial artery spasm were independent predictors of subsequent RAO. Prophylaxis against radial artery spasm and limiting neurointervention via TRA to patients with radial artery larger than 2.5 mm in diameter may reduce the risk of postoperative RAO.

INTERVENTIONAL NEURORADIOLOGY (2023)

Article Clinical Neurology

F-Fluoromisonidazole-Positron Emission Tomography and Immunohistochemistry Verified Tumor Oxygenation, Stemness, and Immunosupportive Microenvironment After Preoperative Neoadjuvant Bevacizumab for Newly Diagnosed Glioblastoma

Tomoya Suzuki, Jun Takei, Nei Fukasawa, Kenta Suzuki, Daisuke Ogawa, Yohei Yamamoto, Yasuharu Akasaki, Yuichi Murayama, Masayuki Shimoda, Keisuke Miyake, Toshihide Tanaka

Summary: This study compared the expressions of carbonic anhydrase 9 (CA9) and Forkhead box M1 (FOXM1) in glioblastoma (GBM) during bevacizumab (Bev) therapy. The results showed that FMISO-PET effectively visualized the oxygenation of tumor microenvironment (TME) after Bev treatment. Increased FMISO accumulation at the time of recurrence, even under Bev treatment, suggests that FMISO-PET might be useful for monitoring the duration of Bev efficacy by reflecting tumor oxygenation.

WORLD NEUROSURGERY (2023)

Article Oncology

Alteration of FOXM1 expression and macrophage polarization in refractory meningiomas during long-term follow-up

Jun Takei, Toshihide Tanaka, Akihiko Teshigawara, Satoru Tochigi, Yuzuru Hasegawa, Yuichi Murayama

Summary: Malignant progression of meningioma is rare, but possible even after initial treatment of low-grade tumors without adjuvant radiotherapy. The expression levels of proliferation markers and macrophages increase in recurrent and malignant meningiomas, suggesting potential for predicting malignant progression. A multidisciplinary approach including radiation and targeted therapy is crucial for managing recurrent and malignant meningiomas.

TRANSLATIONAL CANCER RESEARCH (2021)

No Data Available